Phil Naughten, PharmD is the Vice President of the Value and Evidence Generation Function in the medical affairs department of Takeda Pharmaceuticals USA. Currently, his responsibilities include the oversight of U.S.-focused HEOR activities, Clinical Collaborative and ISR research, as well as the field medical team that works with payer organizations. His team concentrates its efforts on developing and communicating evidence that characterizes the value and appropriate use of products. The team conducts research independently and in collaboration with key academic, payer, and patient group stakeholders that is intended to advance access, improve treatment, and ultimately lead to better patient outcomes. This group’s research works to advance Takeda’s movement towards performance based contracting, focusing efforts on unique constructs to alleviate uncertainty and uncover value.
Prior to these roles, he was responsible for oversight of the U.S. medical field teams, as well as operations and strategy, which included management of alliance relationships and initiating Takeda medical affairs operations in Canada, Mexico, and Brazil. Over his twenty years at Takeda, he has also spent time within the commercial brand and new product teams.
